Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

This week Donanemab, a second new treatment that slows the progression of Alzheimer’s disease has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) but deemed too expensive by the National Institute for Health and Care Excellence (NICE) for widespread use in the NHS. At the same time, DPUK gathered in Nottingham for the latest in our Great Minds events to consider, in the absence of and in addition to accessible treatments, how can you live well with dementia?

Professor of Dementia and Pro-Vice-Chancellor of University of Nottingham, Sube Banerjee MBE, shared what day to day life can be like for someone with a dementia diagnosis and those close to them.  He highlighted four key areas. 

The first was Cognition including a person’s memory and ability to speak and think.  Activities of daily living was the second, essentially the extent to which a person is able to go about their day as they wish or need to without intervention or assistance from others. The third and significant element discussed was Social function. People living with dementia may not want to socialise or feel able to and this can have a negative impact on their overall wellbeing. Finally, Behavioural and Psychological Symptoms of Dementia (BPSD) which are all the other symptoms including things like agitation, depression, sleep disturbances, wandering and delusions.

 QofL Great minds Notts

 

Collectively, cognition, activities of daily living, social function and BPSD will impact quality of life and every person living with dementia will feel differently about what’s most important to them in order to live well with their diagnosis.  The link between symptoms and quality of life is not simple or predictable.

Professor Martin Prince, Professor of Epidemiological Psychiatry at King’s College London and King’s Global Health Institute gave perspectives on quality of life in dementia from lower and middle income countries. He explained that being dependent on someone else for support with daily living was associated with a lower quality of life but that depression and loneliness had the biggest affect on quality of life.

MartinPrinceGreatMindsNotts.jpeg

 

So, whilst there is still a way to go until we have approved and affordable treatments that not only slow the progression of Alzheimer’s disease but potentially halt or even cure it, we need to focus on changing the way we think about ageing and older people. This includes every part of society helping to create an age friendly environment.  Whilst new and future treatments might help to an extent, they can’t and won’t do all the heavy lifting. For now, quality of life and support for carers is perhaps the best health goal. 

 

Further support for living well with dementia

Alzheimer’s Society’s Dementia Friends programme is the biggest ever initiative to change people’s perceptions of dementia. It aims to transform the way the nation thinks, acts and talks about the condition.

Advice from Age UK on Living well with dementia

Activities of daily living - Alzheimer's Research UK

 

More on Great Minds 

Great Minds is a register for healthy volunteers who are interested in helping dementia research studies. 

Whenever you join a health study you are part of a valuable group of people who can help researchers develop new therapies for dementia.  YOU may even hold the key to transforming the success of dementia trials and the search for effective treatments for dementia.

Discover more about how you can help research by joining us at Great Minds

 

What is the new approved treatment and why is it expensive?

 

New Alzheimer’s drug, donanemab – what is it and how does it work? - Alzheimer's Research UK

 

Project information | Donanemab for treating mild cognitive impairment or mild dementia caused by Alzheimer's disease [ID6222] | Guidance | NICE